GENELUX CORP (GNLX)
US36870H1032 - Common Stock
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright
WESTLAKE VILLAGE, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
WESTLAKE VILLAGE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
WESTLAKE VILLAGE, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
– VIRO-25 trial to assess efficacy & safety of olvimulogene nanivacirepvec (Olvi-Vec) & platinum-doublet + physician's choice of immune checkpoint...
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
WESTLAKE VILLAGE, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
WESTLAKE VILLAGE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
GNLX Stock Earnings: Genelux Beats EPS for Q2 2024
GNLX stock results show that Genelux beat analyst estimates for earnings per share the second quarter of 2024.
GNLX Stock Earnings: Genelux Beats EPS for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genelux (NASDAQ:GNLX) just reported results for the second quarter of 2024.Gene...
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
WESTLAKE VILLAGE, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
Genelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024
WESTLAKE VILLAGE, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today...
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants...
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants ...
GNLX Stock Earnings: Genelux Misses EPS for Q1 2024
GNLX stock results show that Genelux missed analyst estimates for earnings per share the first quarter of 2024.
GNLX Stock Earnings: Genelux Misses EPS for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genelux (NASDAQ:GNLX) just reported results for the first quarter of 2024.Genel...